APO Research
Talk to an analyst

APO RESEARCH · REPORT

Full-Service Clinical Research Organization (CRO)

Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.

Selected research

Market Outlook & Growth Opportunities

Global Full-Service Clinical Research Organization (CRO) Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchFull-Service Clinical Research Organization (CRO) Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Full-Service Clinical Research Organization (CRO) Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Full-Service Clinical Research Organization (CRO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Full-Service Clinical Research Organization (CRO) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Full-Service Clinical Research Organization (CRO) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.

Global Full-Service Clinical Research Organization (CRO) key players include IQVIA, Labcorp, Syneos Health, PPD, ICON, etc. Global top three players hold a share about 30%. North America is the largest market, with a share about 45%, followed by APAC and Europe, both have a share about 50 percent.

This report provides an overview of the global Full-Service Clinical Research Organization (CRO) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Full-Service Clinical Research Organization (CRO) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Full-Service Clinical Research Organization (CRO) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Full-Service Clinical Research Organization (CRO) market.

Full-Service Clinical Research Organization (CRO) Segment by Company

IQVIA

Labcorp

Syneos Health

PPD

ICON

PRA

Parexel

Medpace

Wuxi Apptec

EPS International

Worldwide Clinical Trials

CMIC

Premier Research

Courante Oncology

PROMETRIKA

Full-Service Clinical Research Organization (CRO) Segment by Type

Clinical CRO

Preclinical CRO

Full-Service Clinical Research Organization (CRO) Segment by End Use

Small Medium Enterprise

Large Enterprise

Full-Service Clinical Research Organization (CRO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Full-Service Clinical Research Organization (CRO) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Full-Service Clinical Research Organization (CRO) key companies, revenue, market share, and recent developments.

3. To split the Full-Service Clinical Research Organization (CRO) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Full-Service Clinical Research Organization (CRO) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Full-Service Clinical Research Organization (CRO) significant trends, drivers, influence factors in global and regions.

6. To analyze Full-Service Clinical Research Organization (CRO) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Full-Service Clinical Research Organization (CRO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Full-Service Clinical Research Organization (CRO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Full-Service Clinical Research Organization (CRO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Full-Service Clinical Research Organization (CRO) industry.

Chapter 3: Detailed analysis of Full-Service Clinical Research Organization (CRO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Full-Service Clinical Research Organization (CRO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Full-Service Clinical Research Organization (CRO) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Full-Service Clinical Research Organization (CRO) Industry Trends Table 2. Full-Service Clinical Research Organization (CRO) Industry Drivers Table 3. Full-Service Clinical Research Organization (CRO) Industry Opportunities and Challenges Table 4. Full-Service Clinical Research Organization (CRO) Industry Restraints Table 5. Global Full-Service Clinical Research Organization (CRO) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Full-Service Clinical Research Organization (CRO) Revenue Share by Company (2021-2026) Table 7. Global Full-Service Clinical Research Organization (CRO) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Full-Service Clinical Research Organization (CRO) Key Company Manufacturing Base & Headquarters Table 9. Global Full-Service Clinical Research Organization (CRO) Company, Product Type & Application Table 10. Global Full-Service Clinical Research Organization (CRO) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Full-Service Clinical Research Organization (CRO) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Clinical CRO Table 15. Significant Companies of Preclinical CRO Table 16. Global Full-Service Clinical Research Organization (CRO) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Full-Service Clinical Research Organization (CRO) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Full-Service Clinical Research Organization (CRO) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Type (2021-2026) Table 20. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Small Medium Enterprise Table 22. Significant Companies of Large Enterprise Table 23. Global Full-Service Clinical Research Organization (CRO) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Full-Service Clinical Research Organization (CRO) Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Full-Service Clinical Research Organization (CRO) Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Application (2021-2026) Table 27. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Application (2027-2032) Table 28. Global Full-Service Clinical Research Organization (CRO) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Full-Service Clinical Research Organization (CRO) Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Region (2021-2026) Table 31. Global Full-Service Clinical Research Organization (CRO) Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Region (2027-2032) Table 33. Global Full-Service Clinical Research Organization (CRO) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Full-Service Clinical Research Organization (CRO) Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Full-Service Clinical Research Organization (CRO) Sales Value Market Share by Country (2021-2026) Table 36. Global Full-Service Clinical Research Organization (CRO) Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Full-Service Clinical Research Organization (CRO) Sales Value Market Share by Country (2027-2032) Table 38. IQVIA Company Information Table 39. IQVIA Business Overview Table 40. IQVIA Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. IQVIA Full-Service Clinical Research Organization (CRO) Product Portfolio Table 42. IQVIA Recent Development Table 43. Labcorp Company Information Table 44. Labcorp Business Overview Table 45. Labcorp Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Labcorp Full-Service Clinical Research Organization (CRO) Product Portfolio Table 47. Labcorp Recent Development Table 48. Syneos Health Company Information Table 49. Syneos Health Business Overview Table 50. Syneos Health Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Syneos Health Full-Service Clinical Research Organization (CRO) Product Portfolio Table 52. Syneos Health Recent Development Table 53. PPD Company Information Table 54. PPD Business Overview Table 55. PPD Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. PPD Full-Service Clinical Research Organization (CRO) Product Portfolio Table 57. PPD Recent Development Table 58. ICON Company Information Table 59. ICON Business Overview Table 60. ICON Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. ICON Full-Service Clinical Research Organization (CRO) Product Portfolio Table 62. ICON Recent Development Table 63. PRA Company Information Table 64. PRA Business Overview Table 65. PRA Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. PRA Full-Service Clinical Research Organization (CRO) Product Portfolio Table 67. PRA Recent Development Table 68. Parexel Company Information Table 69. Parexel Business Overview Table 70. Parexel Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Parexel Full-Service Clinical Research Organization (CRO) Product Portfolio Table 72. Parexel Recent Development Table 73. Medpace Company Information Table 74. Medpace Business Overview Table 75. Medpace Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Medpace Full-Service Clinical Research Organization (CRO) Product Portfolio Table 77. Medpace Recent Development Table 78. Wuxi Apptec Company Information Table 79. Wuxi Apptec Business Overview Table 80. Wuxi Apptec Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Wuxi Apptec Full-Service Clinical Research Organization (CRO) Product Portfolio Table 82. Wuxi Apptec Recent Development Table 83. EPS International Company Information Table 84. EPS International Business Overview Table 85. EPS International Full-Service Clinical Research Organization (CRO) Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. EPS International Full-Service Clinical Research Organization (CRO) Product Portfolio Table 87. EPS International Recent Development Table 88. Worldwide Clinical Trials Company Information Table 89. Worldwide Clinical Trials Business Overview Table 90. Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Product Portfolio Table 92. Worldwide Clinical Trials Recent Development Table 93. CMIC Company Information Table 94. CMIC Business Overview Table 95. CMIC Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. CMIC Full-Service Clinical Research Organization (CRO) Product Portfolio Table 97. CMIC Recent Development Table 98. Premier Research Company Information Table 99. Premier Research Business Overview Table 100. Premier Research Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Premier Research Full-Service Clinical Research Organization (CRO) Product Portfolio Table 102. Premier Research Recent Development Table 103. Courante Oncology Company Information Table 104. Courante Oncology Business Overview Table 105. Courante Oncology Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Courante Oncology Full-Service Clinical Research Organization (CRO) Product Portfolio Table 107. Courante Oncology Recent Development Table 108. PROMETRIKA Company Information Table 109. PROMETRIKA Business Overview Table 110. PROMETRIKA Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. PROMETRIKA Full-Service Clinical Research Organization (CRO) Product Portfolio Table 112. PROMETRIKA Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Full-Service Clinical Research Organization (CRO) Product Image Figure 2. Global Full-Service Clinical Research Organization (CRO) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Full-Service Clinical Research Organization (CRO) Market Size (2021-2032) & (US$ Million) Figure 4. Global Full-Service Clinical Research Organization (CRO) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Clinical CRO Image Figure 8. Preclinical CRO Image Figure 9. Global Full-Service Clinical Research Organization (CRO) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Full-Service Clinical Research Organization (CRO) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Type (2021-2032) Figure 12. Small Medium Enterprise Image Figure 13. Large Enterprise Image Figure 14. Global Full-Service Clinical Research Organization (CRO) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Full-Service Clinical Research Organization (CRO) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Application (2021-2032) Figure 17. Global Full-Service Clinical Research Organization (CRO) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032) & (US$ Million) Figure 20. North America Full-Service Clinical Research Organization (CRO) Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Full-Service Clinical Research Organization (CRO) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Full-Service Clinical Research Organization (CRO) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032) & (US$ Million) Figure 26. South America Full-Service Clinical Research Organization (CRO) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Full-Service Clinical Research Organization (CRO) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical CRO
  • Preclinical CRO
Applications
  • Small Medium Enterprise
  • Large Enterprise
Companies covered
  • IQVIA
  • Labcorp
  • Syneos Health
  • PPD
  • ICON
  • PRA
  • Parexel
  • Medpace
  • Wuxi Apptec
  • EPS International
  • Worldwide Clinical Trials
  • CMIC
  • Premier Research
  • Courante Oncology
  • PROMETRIKA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Full-Service Clinical Research Organization (CRO) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Full-Service Clinical Research Organization (CRO) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Full-Service Clinical Research Organization (CRO) Market Dynamics
  1. 2.1 Full-Service Clinical Research Organization (CRO) Industry Trends
  2. 2.2 Full-Service Clinical Research Organization (CRO) Industry Drivers
  3. 2.3 Full-Service Clinical Research Organization (CRO) Industry Opportunities and Challenges
  4. 2.4 Full-Service Clinical Research Organization (CRO) Industry Restraints
3 Full-Service Clinical Research Organization (CRO) Market by Company
  1. 3.1 Global Full-Service Clinical Research Organization (CRO) Company Revenue Ranking in 2025
  2. 3.2 Global Full-Service Clinical Research Organization (CRO) Revenue by Company (2021-2026)
  3. 3.3 Global Full-Service Clinical Research Organization (CRO) Company Ranking (2024-2026)
  4. 3.4 Global Full-Service Clinical Research Organization (CRO) Company Manufacturing Base and Headquarters
  5. 3.5 Global Full-Service Clinical Research Organization (CRO) Company Product Type and Application
  6. 3.6 Global Full-Service Clinical Research Organization (CRO) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Full-Service Clinical Research Organization (CRO) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Full-Service Clinical Research Organization (CRO) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Full-Service Clinical Research Organization (CRO) Market by Type
  1. 4.1 Full-Service Clinical Research Organization (CRO) Type Introduction
  2. 4.1.1 Clinical CRO
  3. 4.1.2 Preclinical CRO
  4. 4.2 Global Full-Service Clinical Research Organization (CRO) Sales Value by Type
  5. 4.2.1 Global Full-Service Clinical Research Organization (CRO) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Full-Service Clinical Research Organization (CRO) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Type (2021-2032)
5 Full-Service Clinical Research Organization (CRO) Market by Application
  1. 5.1 Full-Service Clinical Research Organization (CRO) Application Introduction
  2. 5.1.1 Small Medium Enterprise
  3. 5.1.2 Large Enterprise
  4. 5.2 Global Full-Service Clinical Research Organization (CRO) Sales Value by Application
  5. 5.2.1 Global Full-Service Clinical Research Organization (CRO) Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Full-Service Clinical Research Organization (CRO) Sales Value by Application (2021-2032)
  7. 5.2.3 Global Full-Service Clinical Research Organization (CRO) Sales Value Share by Application (2021-2032)
6 Full-Service Clinical Research Organization (CRO) Regional Value Analysis
  1. 6.1 Global Full-Service Clinical Research Organization (CRO) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Full-Service Clinical Research Organization (CRO) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Full-Service Clinical Research Organization (CRO) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Full-Service Clinical Research Organization (CRO) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032)
  7. 6.3.2 North America Full-Service Clinical Research Organization (CRO) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032)
  10. 6.4.2 Europe Full-Service Clinical Research Organization (CRO) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Full-Service Clinical Research Organization (CRO) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032)
  16. 6.6.2 South America Full-Service Clinical Research Organization (CRO) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Full-Service Clinical Research Organization (CRO) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Full-Service Clinical Research Organization (CRO) Sales Value Share by Country, 2025 VS 2032
7 Full-Service Clinical Research Organization (CRO) Country-level Value Analysis
  1. 7.1 Global Full-Service Clinical Research Organization (CRO) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Full-Service Clinical Research Organization (CRO) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Full-Service Clinical Research Organization (CRO) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Full-Service Clinical Research Organization (CRO) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Full-Service Clinical Research Organization (CRO) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Full-Service Clinical Research Organization (CRO) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Full-Service Clinical Research Organization (CRO) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IQVIA
  2. 8.1.1 IQVIA Company Information
  3. 8.1.2 IQVIA Business Overview
  4. 8.1.3 IQVIA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IQVIA Full-Service Clinical Research Organization (CRO) Product Portfolio
  6. 8.1.5 IQVIA Recent Developments
  7. 8.2 Labcorp
  8. 8.2.1 Labcorp Company Information
  9. 8.2.2 Labcorp Business Overview
  10. 8.2.3 Labcorp Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Labcorp Full-Service Clinical Research Organization (CRO) Product Portfolio
  12. 8.2.5 Labcorp Recent Developments
  13. 8.3 Syneos Health
  14. 8.3.1 Syneos Health Company Information
  15. 8.3.2 Syneos Health Business Overview
  16. 8.3.3 Syneos Health Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Syneos Health Full-Service Clinical Research Organization (CRO) Product Portfolio
  18. 8.3.5 Syneos Health Recent Developments
  19. 8.4 PPD
  20. 8.4.1 PPD Company Information
  21. 8.4.2 PPD Business Overview
  22. 8.4.3 PPD Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PPD Full-Service Clinical Research Organization (CRO) Product Portfolio
  24. 8.4.5 PPD Recent Developments
  25. 8.5 ICON
  26. 8.5.1 ICON Company Information
  27. 8.5.2 ICON Business Overview
  28. 8.5.3 ICON Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ICON Full-Service Clinical Research Organization (CRO) Product Portfolio
  30. 8.5.5 ICON Recent Developments
  31. 8.6 PRA
  32. 8.6.1 PRA Company Information
  33. 8.6.2 PRA Business Overview
  34. 8.6.3 PRA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PRA Full-Service Clinical Research Organization (CRO) Product Portfolio
  36. 8.6.5 PRA Recent Developments
  37. 8.7 Parexel
  38. 8.7.1 Parexel Company Information
  39. 8.7.2 Parexel Business Overview
  40. 8.7.3 Parexel Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Parexel Full-Service Clinical Research Organization (CRO) Product Portfolio
  42. 8.7.5 Parexel Recent Developments
  43. 8.8 Medpace
  44. 8.8.1 Medpace Company Information
  45. 8.8.2 Medpace Business Overview
  46. 8.8.3 Medpace Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medpace Full-Service Clinical Research Organization (CRO) Product Portfolio
  48. 8.8.5 Medpace Recent Developments
  49. 8.9 Wuxi Apptec
  50. 8.9.1 Wuxi Apptec Company Information
  51. 8.9.2 Wuxi Apptec Business Overview
  52. 8.9.3 Wuxi Apptec Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wuxi Apptec Full-Service Clinical Research Organization (CRO) Product Portfolio
  54. 8.9.5 Wuxi Apptec Recent Developments
  55. 8.10 EPS International
  56. 8.10.1 EPS International Company Information
  57. 8.10.2 EPS International Business Overview
  58. 8.10.3 EPS International Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EPS International Full-Service Clinical Research Organization (CRO) Product Portfolio
  60. 8.10.5 EPS International Recent Developments
  61. 8.11 Worldwide Clinical Trials
  62. 8.11.1 Worldwide Clinical Trials Company Information
  63. 8.11.2 Worldwide Clinical Trials Business Overview
  64. 8.11.3 Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Product Portfolio
  66. 8.11.5 Worldwide Clinical Trials Recent Developments
  67. 8.12 CMIC
  68. 8.12.1 CMIC Company Information
  69. 8.12.2 CMIC Business Overview
  70. 8.12.3 CMIC Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CMIC Full-Service Clinical Research Organization (CRO) Product Portfolio
  72. 8.12.5 CMIC Recent Developments
  73. 8.13 Premier Research
  74. 8.13.1 Premier Research Company Information
  75. 8.13.2 Premier Research Business Overview
  76. 8.13.3 Premier Research Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Premier Research Full-Service Clinical Research Organization (CRO) Product Portfolio
  78. 8.13.5 Premier Research Recent Developments
  79. 8.14 Courante Oncology
  80. 8.14.1 Courante Oncology Company Information
  81. 8.14.2 Courante Oncology Business Overview
  82. 8.14.3 Courante Oncology Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Courante Oncology Full-Service Clinical Research Organization (CRO) Product Portfolio
  84. 8.14.5 Courante Oncology Recent Developments
  85. 8.15 PROMETRIKA
  86. 8.15.1 PROMETRIKA Company Information
  87. 8.15.2 PROMETRIKA Business Overview
  88. 8.15.3 PROMETRIKA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PROMETRIKA Full-Service Clinical Research Organization (CRO) Product Portfolio
  90. 8.15.5 PROMETRIKA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst